Skip to main content
Log in

Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

To investigate the temporal expressions of IL-9 and its related cytokines after middle cerebral artery occlusion in rats. IL-9 and its related cytokines in ischemia brain and blood were tested after rats were subjected to transient focal ischemia. Comparing with sham-operated group, the levels of IL-4, TGF-β, PU.1, IRF4, OX40, NIK, RelB-p52 and IL-9 in experimental groups were significantly higher after middle cerebral artery occlusion. The results showed that expressions of IL-9 and its upstream stimulating factors increased in experimental stroke, and whether they play a role or just a secondary change is awaiting further research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Guan T, Liu Q, Qian Y, Yang H, Kong J, Kou J, Yu B (2013) Ruscogenin reduces cerebral ischemic injury via NF-kappaB-mediated inflammatory pathway in the mouse model of experimental stroke. Eur J Pharmacol 714:303–311

    Article  CAS  PubMed  Google Scholar 

  2. Liu L, Wang D, Wong KS, Wang Y (2011) Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42:3651–3654

    Article  PubMed  Google Scholar 

  3. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819–834

    Article  CAS  PubMed  Google Scholar 

  4. Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127–136

    CAS  PubMed  Google Scholar 

  5. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183:7169–7177

    Article  PubMed Central  PubMed  Google Scholar 

  6. Chang HC, Sehra S, Goswami R et al (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Yao W, Tepper RS, Kaplan MH (2011) Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol 128(1357–60):e1355

    Google Scholar 

  8. Bullens DM, Kasran A, Dilissen E et al (2011) In vivo maturation of T(H) cells in relation to atopy. J Allergy Clin Immunol 128(234–7):e7

    PubMed  Google Scholar 

  9. Erpenbeck VJ, Hohlfeld JM, Volkmann B et al (2003) Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 111:1319–1327

    Article  CAS  PubMed  Google Scholar 

  10. Shimbara A, Christodoulopoulos P, Soussi-Gounni A et al (2000) IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 105:108–115

    Article  CAS  PubMed  Google Scholar 

  11. Temann UA, Laouar Y, Eynon EE, Homer R, Flavell RA (2007) IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 19:1–10

    Article  CAS  PubMed  Google Scholar 

  12. Cheng G, Arima M, Honda K (2002) Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 166:409–416

    Article  PubMed  Google Scholar 

  13. Zhao P, Xiao X, Ghobrial RM, Li XC (2013) IL-9 and Th9 cells: progress and challenges. Int Immunol 25:547–551

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933–944

    Article  CAS  PubMed  Google Scholar 

  15. Ansel KM, Djuretic I, Tanasa B, Rao A (2006) Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24:607–656

    Article  CAS  PubMed  Google Scholar 

  16. Szabo SJ, Kim ST, Costa GL et al (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655

    Article  CAS  PubMed  Google Scholar 

  17. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852

    Article  CAS  PubMed  Google Scholar 

  18. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775–787

    Article  CAS  PubMed  Google Scholar 

  19. Perumal NB, Kaplan MH (2011) Regulating Il9 transcription in T helper cells. Trends Immunol 32:146–150

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91

    Article  CAS  PubMed  Google Scholar 

  21. Swanson RA, Sharp FR (1994) Infarct measurement methodology. J Cereb Blood Flow Metab 14:697–698

    Article  CAS  PubMed  Google Scholar 

  22. Zheng LF, Wang R, Xu YZ et al (2008) Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries. Brain Res 1187:20–32

    Article  CAS  PubMed  Google Scholar 

  23. Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677–685

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Zhou Y, Sonobe Y, Akahori T et al (2011) IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 186:4415–4421

    Article  CAS  PubMed  Google Scholar 

  25. Yamasaki Y, Matsuura N, Shozuhara H et al (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676–680 (discussion 681)

    Article  CAS  PubMed  Google Scholar 

  26. Yang GY, Gong C, Qin Z et al (1998) Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. NeuroReport 9:2131–2134

    Article  CAS  PubMed  Google Scholar 

  27. Barone FC, Arvin B, White RF et al (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233–1244

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study is funded by the Role of New Th9 Cells on the Mechanism of Malignant MCA Infarction and the Change of TH9 after MSCs Implanting Ischemic Stroke Mice (No. 81271328), National Natural Science Foundation.

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhengqi Lu.

Additional information

Y. Lin, L. Zhang and Y. Dai contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, Y., Zhang, L., Dai, Y. et al. Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke. Neurol Sci 36, 913–920 (2015). https://doi.org/10.1007/s10072-015-2096-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-015-2096-2

Keywords

Navigation